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INTRODUCTION
The latest global estimates show that 382 million people had diabetes in
2013, and will rise to 592 million by 2035. The rise of diabetes is a major
issue across the world. “The disease burden related to diabetes is rising
and fueled by the global rise in the prevalence of obesity and unhealthy
lifestyles” (Forouhi & Wareham, 2014). “Both forms of diabetes can lead
to multisystem complications of microvascular endpoints, including
retinopathy, nephropathy and neuropathy, and macrovascular endpoints
including ischemic heart disease, stroke and peripheral vascular disease”
(Forouhi & Wareham, 2014). Of the two types of diabetes, type II
diabetes is seen to be the most prevalent. Type II diabetes is a lifelong
chronic disease which is caused by high levels of blood glucose in the
blood.
Insulin is a major hormone produced in the pancreas by beta cells. The
hormone moves blood sugar glucose into different cells. Once the glucose
is inside the cells, it is stored and later used for energy. When a person has
type II diabetes, their fat, liver, and muscle cells do not respond to insulin
correctly, this is called insulin resistance. Insulin resistance prevents the
sugar to be used for energy. The blood glucose continues to build up
inside the body because it is not going inside the different cells. Type II
diabetes occurs over a period of time. “The causes of type II diabetes are
multi-factorial and include both genetic and environmental elements that
affect beta cell function and tissue (muscle, liver, adipose tissue,
pancreas) insulin sensitivity” (Scheen, 2003). Insulin resistance and beta
cell dysfunction is in the pathogenesis of type 2 diabetes. There are
different prevention strategies that can be installed for a person that has
type 2 diabetes. “Oral pharmacological agents used to treat type 2
diabetes that improve insulin sensitivity, preserve beta cell function that
delay carbohydrate metabolism have been shown to prevent the
progression of impaired glucose tolerance to type 2 diabetes” (SmithMarsh, 2013).
Type II diabetes is diagnosed by a blood test called Glycated hemoglobin
A1C. This test shows the average blood sugar level from previous
months. Normal levels are below 5.7%, results that are between 5.7% and
6.4% are considered prediabetes. A result that is higher is 6.5% on two
separate occasions implies that diabetes is present. If a glycated
hemoglobin test is not available then a doctor can use a random blood
sugar test, fasting blood sugar test, or oral glucose tolerance test. For a
random blood sugar test a reading that is 200 mg/dL or higher suggests
that diabetes is present. For a fasting blood sugar test a reading that is 126
mg/dL or higher on two separate test suggest that diabetes is present. For
an oral glucose tolerance test a reading that is 200 mg/dL or higher
suggests that diabetes is present.

EXERCISE TESTING

EXERCISE PRESCRIPTION

Individuals with type II diabetes need to be medically cleared before starting a
vigorous exercise program and should undergo a thorough medical evaluation. If an
individual with type II diabetes has a greater than 10% risk of a cardiac event, the
individual should complete a medically supervised maximal clinical exercise test
before starting the program. Silent ischemia is common with people who have type
II diabetes, they will need to undergo a clinical exercise test with a radionuclide
injection that allows for detection of ischemic areas of the heart. Those who present
risks to be hypoglycemic during exercise need to be monitored closely, the exercise
professional has to be aware of oral agents and insulin preparations because
exercise cannot occur during the peak of insulin action. During each session blood
glucose should be monitored before and after each session and also before starting
an exercise program. With type II diabetes the clients blood glucose should not be
more than 199 mg/dl. If an individual’s blood glucose is <100 mg/dl, the client
should ingest 20 to 30 g of carbohydrate before starting exercise. Even after
ingestion the glucose level should be measured every 10 minutes afterward. If
insulin needs to be injected, it should not be injected into exercising limbs. For most
clients it is ideal to inject them in the abdominal site, especially if blood glucose is
above 200 mg/dl.
Ketone bodies can be checked in urine and if none are present, light to moderate
exercise is possible, but no vigorous exercise should be involved. Type II diabetes
puts individuals at a higher risk for dehydration during exercise, so hydration status
should be monitored. Individuals with retinopathy should avoid vigorous-intensity
exercise. Individuals with autonomic neuropathy should be referred to a medically
supervised program. Individuals with type II diabetes and kidney disease, peripheral
artery disease, or peripheral neuropathy also should go to a medically supervised
program, because the risk is just too high. Vigorous exercise in patients with type II
diabetes should always be cautious due to undiagnosed atherosclerosis of the
coronary and peripheral arteries. Unfortunately, 75% of individuals with type II
diabetes will die from cardiovascular disease.

EXERCISE PRESCRIPTION
Aerobic Exercise

Frequency
Intensity
Time

• Sedentary: 30 min of aerobic
activity 5-7x/week
• Active: 30 min of aerobic
activity 5-7x/week

• 50-85% of HRR
• 12-16 rating on RPE scale

• 10-30 min sessions
• If weight loss is needed:
• 60 minute sessions
• 150-300 min per week

Resistance Training

• 2-3 days
per week

• 50-70% of
1RM

• 30-60 min
sessions

• Aerobic training should progress at no more than 10% increase per week
in exercise intensity (Williams, et al, 2018).
• Aerobic training benefits:
• Enhances glucose delivery to exercising muscles
• Stimulates translocation of glucose transporter protein
• Improves insulin receptor sensitivity
• Resistance training progression should occur slowly, and only if number
of reps/set can be consistently exceeded each week (Williams, et al,
2018).
• Resistance training benefits:
• Increases insulin receptors
• Increased capacity for glucose intake

SPECIAL CONSIDERATIONS
• The exercise prescription should be accompanied with a low-fat, high fiber
diet. When these are paired together, there is significant reduction for the
risk of developing type II diabetes (Jacobs, 2018)
• Hypoglycemia is a common abnormal response to exercise
• Blood glucose levels need to be monitored before, during, and after exercise
• Hydration levels need to be monitored due to increased risk of dehydration

CONCLUSION
Exercising with type II diabetes can help increase the quality of life and
has been essential to prevent and manage type II diabetes. Exercise will
increase insulin sensitivity helping a person live a healthier lifestyle.
Daily exercise will also provide an alternative mechanism for blood
glucose disposal. When exercise is done regularly, a 71% reduction in the
risk for developing type II diabetes has been seen. Long-term exercise
with resistance training increases fat-free mass, causing an increased
insulin receptors and capacity for glucose uptake to better manage type II
diabetes as well as glycated hemoglobin levels that improve with both
resistance training and aerobic training.
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• Rhythmic and continuous
• Emphasize working large
muscle groups

• Free weight
exercises
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